Your browser doesn't support javascript.
loading
Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients.
Ueda, Rikako; Yamamoto, Naho; Hori, Yuki; Yoshida, Kouji; Ohtsubo, Koushiro; Terashima, Takeshi; Shimada, Tsutomu; Sai, Yoshimichi.
Afiliação
  • Ueda R; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan. rikakko88@staff.kanazawa-u.ac.jp.
  • Yamamoto N; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Hori Y; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Yoshida K; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Ohtsubo K; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Terashima T; Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Shimada T; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
  • Sai Y; Department of Hospital Pharmacy, University Hospital, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.
J Pharm Health Care Sci ; 8(1): 5, 2022 Feb 02.
Article em En | MEDLINE | ID: mdl-35105386

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article